Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia

Schizophrenia Bulletin

Volumn 38, Issue 3, 2012, Pages 543-551

  Kelly, Deanna L ^a   Raley, Heather G ^a   Lo, Suzanne ^b   Wright, Katherine ^a   Liu, Fang ^a   McMahon, Robert P ^a   Moolchan, Eric T ^c   Feldman, Stephanie ^a   Richardson, Charles M ^a   Wehring, Heidi J ^a   Heishman, Stephen J ^b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c ALKERMES INC   (United States)

Author keywords

health risks; motivation; schizophrenia; smoking

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; BREATH ANALYSIS; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING CESSATION; SOCIAL BEHAVIOR; SOCIAL PROBLEM; TOBACCO DEPENDENCE;

ADULT; COMORBIDITY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; QUESTIONNAIRES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SMOKING CESSATION;

EID: 84860113644     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbq124     Document Type: Article

References (44)

1. Moeller-Saxone K. Cigarette smoking and interest in quitting among consumers at a Psychiatric Disability Rehabilitation and Support Service in Victoria. Aust N Z J Public Health. 2008;32:479-481.
2. Chaves L, Shirakawa I. Nicotine use in patients with schizophrenia evaluated by the Fagerstrom Tolerance Questionnaire: a descriptive analysis from a Brazilian sample. Rev Bras Psiquiatr. 2008;30:350-352.
3. National Survey ofDrugUse andHealth (NSDUH).USDepartment ofHealth andHuman Services, Substance Abuse andMental Health Services Administration 2009. http://www.oas.samhsa. gov/NSDUH/2k8NSDUH/2k8results.cfm#Ch4. Accessed December 4, 2009.
4. Baker A, Richmond R, Haile M, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry. 2006;163: 1934-1942. (Pubitemid 44807785)
5. Herran A, de Santiago A, Sandoya M, Fernandez MJ, Diez-Manrique JF, Vazquez-Barquero JL. Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr Res. 2000;41:373-381. (Pubitemid 30077480)
6. Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry. 1999;156: 1751-1757. (Pubitemid 29517568)
7. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143:993-997. (Pubitemid 16073948)
8. Simosky JK, Stevens KE, Freedman R. Nicotinic agonists and psychosis. Curr Drug Targets CNS Neurol Disord. 2002;1:149-162.
9. Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry. 2001;49:258-267. (Pubitemid 32178435)
10. Hutchison KE, Niaura R, Swift R. The effects of smoking high nicotine cigarettes on prepulse inhibition, startle latency, and subjective responses. Psychopharmacology (Berl). 2000; 150:244-252. (Pubitemid 30447843)
11. Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry. 2004;55:850-858. (Pubitemid 38429877)
12. Barr RS, Culhane MA, Jubelt LE, et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008;33:480-490.
13. Barnes M, Lawford BR, Burton SC, et al. Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Aust N Z J Psychiatry. 2006;40:575-580. (Pubitemid 43805628)
14. Martin LF, Freedman R. Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int Rev Neurobiol. 2007;78:225-246.
15. Lambe EK, Picciotto MR, Aghajanian GK. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology. 2003;28:216-225.
16. Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol. 2006;26:365-384.
17. Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull. 2010;83:108-121.
18. Kelly DL, McMahon RP, Wehring HJ, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37(4):832-838.
19. Curry S, Wagner EH, Grothaus LC. Intrinsic and extrinsic motivation for smoking cessation. J Consult Clin Psychol. 1990;58:310-316. (Pubitemid 20301164)
20. Williams JM, Foulds J. Successful tobacco dependence treatment in schizophrenia. Am J Psychiatry. 2007;164:222-227 quiz 373.
21. Fagerstrom K, Aubin HJ. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin. 2009;25:511-518.
22. de Leon J, Susce MT, Diaz FJ, Rendon DM, Velasquez DM. Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry. 2005;66:1447-1455. (Pubitemid 41779544)
23. Copeland AL, Brandon TH, Quinn EP. The Smoking Consequences Questionnaire-Adult: measurement of smoking outcome expectancies of experienced smokers. Psycholo Assess. 1995;7:484-493.
24. Boardman T, Catley D, Mayo MS, Ahluwalia JS. Selfefficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med. 2005;12:266-272. (Pubitemid 41566764)
25. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2010;6:CD007253.
26. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction.105:1176-1189.
27. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71-93.
28. Buckley TC, Kamholz BW, Mozley SL, et al. A psychometric evaluation of the Smoking Consequences Questionnaire-Adult in smokers with psychiatric conditions. Nicotine Tob Res. 2005;7:739-745. (Pubitemid 41700975)
29. Curry SJ, Grothaus L, McBride C. Reasons for quitting: intrinsic and extrinsic motivation for smoking cessation in a population-based sample of smokers. Addict Behav. 1997;22:727-739. (Pubitemid 27511993)
30. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
31. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59:295-304.
32. Heishman SJ, Singleton EG, Pickworth WB. Reliability and validity of a Short Form of the Tobacco Craving Questionnaire. Nicotine Tob Res. 2008;10:643-651. (Pubitemid 351566550)
33. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11:51-62.
34. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289-300.
35. Tidey JW, Rohsenow DJ. Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls. Schizophr Res. 2009;115:310-316.
36. Spring B, Pingitore R, McChargue DE. Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry. 2003;160:316-322. (Pubitemid 41110458)
37. Forchuk C, Norman R, Malla A, et al. Schizophrenia and the motivation for smoking. Perspect Psychiatr Care. 2002;38:41-49.
38. Baker A, Richmond R, Haile M, et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Res. 2007;150:141-152. (Pubitemid 46386295)
39. Lucksted A, Dixon LB, Sembly JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatr Serv. 2000;51:1544-1548.
40. Barr AM, Procyshyn RM, Hui P, Johnson JL, Honer WG. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophr Res. 2008;100:252-260.
41. Gurpegui M, Martinez-Ortega JM, Jurado D, Aguilar MC, Diaz FJ, de Leon J. Subjective effects and the main reason for smoking in outpatients with schizophrenia: a case-control study. Compr Psychiatry. 2007;48:186-191. (Pubitemid 46204669)
42. Roll JM, Higgins ST, Steingard S, McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Exp Clin Psychopharmacol. 1998;6:157-161. (Pubitemid 28253075)
43. Tidey JW, O'Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Exp Clin Psychopharmacol. 2002;10:241-247. (Pubitemid 34919932)
44. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull. 1998;24:443-455. (Pubitemid 28378229)